Agilent Technologies (NYSE:A) reported better-than-expected revenue in Q2 CY2025, with a 10.1% year-on-year sales increase to $1.74 billion. Next quarter’s revenue guidance of $1.83 billion at the midpoint exceeded analyst expectations by 3.4%. Non-GAAP profit of $1.37 per share matched consensus estimates. Company overview: Agilent provides analytical instruments, software, and services for life sciences, diagnostics, and chemical markets. Over the last five years, Agilent’s sales grew at a 5.4% compounded annual rate, with an operating margin of 20.7%. EPS grew 11.3% annually, indicating increased profitability. Stock remained flat at $26.89 post-results.

Read more at Stockstory.org does not appear to be associated with a specific media company.: Agilent’s (NYSE:A) Q2 Sales Top Estimates, Full-Year Sales Guidance is Optimistic